Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)
China flag China · Delayed Price · Currency is CNY
58.08
-0.78 (-1.33%)
Sep 6, 2024, 3:00 PM CST

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Revenue

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had revenue of 132.45M CNY in the quarter ending June 30, 2024, with 18.45% growth. This brings the company's revenue in the last twelve months to 407.21M, down -2.31% year-over-year. In the year 2023, Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had annual revenue of 386.44M with 27.83% growth.

Revenue (ttm)
407.21M
Revenue Growth
-2.31%
P/S Ratio
37.72
Revenue / Employee
474.60K
Employees
867
Market Cap
15.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023386.44M84.13M27.83%
Dec 31, 2022302.31M111.94M58.81%
Dec 31, 2021190.36M162.70M588.19%
Dec 31, 202027.66M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition